215 related articles for article (PubMed ID: 31258538)
1. Synthetic Lipopeptide Enhances Protective Immunity Against
Xue RY; Guo MF; Guo L; Liu C; Li S; Luo J; Nie L; Ji L; Ma CJ; Chen DQ; Sun S; Jin Z; Zou QM; Li HB
Front Immunol; 2019; 10():1372. PubMed ID: 31258538
[TBL] [Abstract][Full Text] [Related]
2. The rOmp22-HpaA fusion protein confers protective immunity against helicobacter pylori in mice.
Huang X; Xu B; Duan G; Song C
Curr Microbiol; 2013 Oct; 67(4):487-92. PubMed ID: 23715666
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background.
Sutton P; Doidge C; Pinczower G; Wilson J; Harbour S; Swierczak A; Lee A
FEMS Immunol Med Microbiol; 2007 Jul; 50(2):213-9. PubMed ID: 17567282
[TBL] [Abstract][Full Text] [Related]
4. [Immunoprotective effects of Helicobacter pylori UreB and HpaA bivalence recombinant vaccine with inner adjuvant on experimental infection in mice].
Mao YF; Yan J; Xu Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 34(5):405-11. PubMed ID: 16216050
[TBL] [Abstract][Full Text] [Related]
5. Recombinant HpaA purified from Escherichia coli has biological properties similar to those of native Helicobacter pylori HpaA.
Lundstrom A; Bolin I; Bystrom M; Nystrom S
APMIS; 2003 Mar; 111(3):389-97. PubMed ID: 12752218
[TBL] [Abstract][Full Text] [Related]
6. [In vitro study of the biological activities and immunogenicity of recombinant adhesin of Heliobacter pylori rHpaA].
Chen Y; Wang J; Shi L
Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(5):276-9. PubMed ID: 11798887
[TBL] [Abstract][Full Text] [Related]
7. Surface expression of Helicobacter pylori HpaA adhesion antigen on Vibrio cholerae, enhanced by co-expressed enterotoxigenic Escherichia coli fimbrial antigens.
Tobias J; Lebens M; Wai SN; Holmgren J; Svennerholm AM
Microb Pathog; 2017 Apr; 105():177-184. PubMed ID: 28215587
[TBL] [Abstract][Full Text] [Related]
8. Immunologic properties and therapeutic efficacy of a multivalent epitope-based vaccine against four Helicobacter pylori adhesins (urease, Lpp20, HpaA, and CagL) in Mongolian gerbils.
Guo L; Yin R; Xu G; Gong X; Chang Z; Hong D; Liu H; Ding S; Han X; Li Y; Tang F; Liu K
Helicobacter; 2017 Dec; 22(6):. PubMed ID: 28851031
[TBL] [Abstract][Full Text] [Related]
9. Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses.
Nyström J; Svennerholm AM
Vaccine; 2007 Mar; 25(14):2591-8. PubMed ID: 17239498
[TBL] [Abstract][Full Text] [Related]
10. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
[TBL] [Abstract][Full Text] [Related]
11. TLR2 mediates Helicobacter pylori-induced tolerogenic immune response in mice.
Sun X; Zhang M; El-Zataari M; Owyang SY; Eaton KA; Liu M; Chang YM; Zou W; Kao JY
PLoS One; 2013; 8(9):e74595. PubMed ID: 24058595
[TBL] [Abstract][Full Text] [Related]
12. A truncated form of HpaA is a promising antigen for use in a vaccine against Helicobacter pylori.
Flach CF; Svensson N; Blomquist M; Ekman A; Raghavan S; Holmgren J
Vaccine; 2011 Feb; 29(6):1235-41. PubMed ID: 21147129
[TBL] [Abstract][Full Text] [Related]
13. Protection against Helicobacter pylori infection by a trivalent fusion vaccine based on a fragment of urease B-UreB414.
Wang L; Liu XF; Yun S; Yuan XP; Mao XH; Wu C; Zhang WJ; Liu KY; Guo G; Lu DS; Tong WD; Wen AD; Zou QM
J Microbiol; 2010 Apr; 48(2):223-8. PubMed ID: 20437155
[TBL] [Abstract][Full Text] [Related]
14. Immunodominant epitope-specific Th1 but not Th17 responses mediate protection against Helicobacter pylori infection following UreB vaccination of BALB/c mice.
Li B; Chen L; Sun H; Yang W; Hu J; He Y; Wei S; Zhao Z; Zhang J; Li H; Zou Q; Wu C
Sci Rep; 2015 Oct; 5():14793. PubMed ID: 26434384
[TBL] [Abstract][Full Text] [Related]
15. Unraveling the crystal structure of the HpaA adhesin: insights into cell adhesion function and epitope localization of a
Martini C; Araba V; Beniani M; Armoa Ortiz P; Simmons M; Chalbi M; Mellouk A; El Bakkouri M; Calmettes C
mBio; 2024 Mar; 15(3):e0295223. PubMed ID: 38376163
[No Abstract] [Full Text] [Related]
16. The mucosal adjuvant effect of plant polysaccharides for induction of protective immunity against Helicobacter pylori infection.
Liu C; Luo J; Xue RY; Guo L; Nie L; Li S; Ji L; Ma CJ; Chen DQ; Miao K; Zou QM; Li HB
Vaccine; 2019 Feb; 37(8):1053-1061. PubMed ID: 30665774
[TBL] [Abstract][Full Text] [Related]
17. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
[TBL] [Abstract][Full Text] [Related]
18. Th1-mediated immunity against Helicobacter pylori can compensate for lack of Th17 cells and can protect mice in the absence of immunization.
Ding H; Nedrud JG; Blanchard TG; Zagorski BM; Li G; Shiu J; Xu J; Czinn SJ
PLoS One; 2013; 8(7):e69384. PubMed ID: 23874957
[TBL] [Abstract][Full Text] [Related]
19. Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection.
Shi T; Liu WZ; Gao F; Shi GY; Xiao SD
Helicobacter; 2005 Feb; 10(1):71-9. PubMed ID: 15691317
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of oral immunization with a non-genetically modified Lactococcus lactis-based vaccine CUE-GEM induces local immunity against Helicobacter pylori infection.
Liu W; Tan Z; Xue J; Luo W; Song H; Lv X; Zheng T; Xi T; Xing Y
Appl Microbiol Biotechnol; 2016 Jul; 100(14):6219-6229. PubMed ID: 26846746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
